| |
 |
|
Class Information
Number: 424/188.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same > Disclosed amino acid sequence derived from virus > Retroviridae (e.g., feline leukemia, etc.) > Immunodeficiency virus (e.g., hiv, etc.)
Description: Subject matter wherein the virus is one that is associated with an immunodeficiency syndrome such as AIDS in humans or an AIDS-related syndrome in animals.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7361459 |
Antiviral inhibition of capsid proteins |
Apr. 22, 2008 |
| 7351412 |
Cloned DNA sequences related to the genomic RNA of lymphadenopathy-associated-virus (LAV) and proteins encoded by said LAV genomic RNA |
Apr. 1, 2008 |
| 7348136 |
Method and device for detecting feline immunodeficiency virus |
Mar. 25, 2008 |
| 7335365 |
HIV-encoded chemoattractant |
Feb. 26, 2008 |
| 7335360 |
Method and device for detecting feline immunodeficiency virus |
Feb. 26, 2008 |
| 7318927 |
Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
Jan. 15, 2008 |
| 7311916 |
Methods of eliciting broadly neutralizing antibodies targeting HIV-1 gp41 |
Dec. 25, 2007 |
| 7306804 |
HIV-specific T-cell induction |
Dec. 11, 2007 |
| 7297784 |
DNA encoding T-1249 and other viral fusion inhibitor peptides useful for treating aids |
Nov. 20, 2007 |
| 7291337 |
Peptide having an affinity for gp120 |
Nov. 6, 2007 |
| 7291338 |
Method and device for detecting feline immunodeficiency virus |
Nov. 6, 2007 |
| 7285278 |
Method and device for detecting feline immunodeficiency virus |
Oct. 23, 2007 |
| 7285272 |
Method and device for detecting feline immunodeficiency virus |
Oct. 23, 2007 |
| 7285271 |
Antigenic composition comprising an HIV gag or env polypeptide |
Oct. 23, 2007 |
| 7276333 |
Viral infection inhibitor targeting integrase N-terminal domain |
Oct. 2, 2007 |
| 7276242 |
Vipox vector coding an HIV antigen and a cytokine |
Oct. 2, 2007 |
| 7273614 |
Nucleic acids encoding DP-178 and other viral fusion inhibitor peptides useful for treating aids |
Sep. 25, 2007 |
| 7273695 |
HIV immunoassays using synthetic envelope polypeptides |
Sep. 25, 2007 |
| 7262270 |
Fusion protein construct and method for inducing HIV-specific serum IgG and secretory IgA antibodies in-vivo |
Aug. 28, 2007 |
| 7255862 |
ALVAC/FIV constructs |
Aug. 14, 2007 |
| 7232685 |
Cell lines with latent immunodeficiency virus and methods of use thereof |
Jun. 19, 2007 |
| 7226598 |
Peptide inhibitors of HIV entry |
Jun. 5, 2007 |
| 7220826 |
Expressing gp140 fragment of primary HIV-1 isolate |
May. 22, 2007 |
| 7201903 |
Method and device for detecting feline immunodeficiency virus |
Apr. 10, 2007 |
| 7195768 |
Polyvalent immunogen |
Mar. 27, 2007 |
| 7179468 |
Antigen for developing neutralizing antibodies to human immunodeficiency virus |
Feb. 20, 2007 |
| 7172761 |
Polyvalent immunogen |
Feb. 6, 2007 |
| 7157225 |
Nucleotide sequences of HIV-1 type (or subtype) O retrovirus antigens |
Jan. 2, 2007 |
| 7153509 |
Immunogenic peptides comprising a T-helper epitope and a B-cell neutralizing antibody epitope |
Dec. 26, 2006 |
| 7138119 |
Compositions and methods for inhibition of HIV-1 infection |
Nov. 21, 2006 |
| 7122190 |
Fusion proteins comprising DP-178 and other viral fusion inhibitor peptides useful for treating aids |
Oct. 17, 2006 |
| 7118751 |
DNA vaccines encoding antigen linked to a domain that binds CD40 |
Oct. 10, 2006 |
| 7115363 |
Retrovirus capable of causing AIDS, means and methods for detecting it in vitro |
Oct. 3, 2006 |
| 7105164 |
HIV-specific cytotoxic T-cell responses |
Sep. 12, 2006 |
| 7097971 |
HIV-1 peptide, antigen, immunogenic composition, diagnostic method and immunoassay kit |
Aug. 29, 2006 |
| 7097841 |
Ferritin fusion proteins for use in vaccines and other applications |
Aug. 29, 2006 |
| 7094408 |
Immunogenicity using a combination of DNA and vaccinia virus vector vaccines |
Aug. 22, 2006 |
| 7094405 |
Peptides which elicit a high neutralizing antibody titer, cytotoxic T lymphocyte response and T helper cell response in a broad range of MHC type recipients |
Aug. 22, 2006 |
| 7090848 |
HIV-1 envelope protein associated with a broadly reactive neutralizing antibody response |
Aug. 15, 2006 |
| 7090851 |
Long lasting fusion peptide inhibitors of viral infection |
Aug. 15, 2006 |
| 7087375 |
Method for determining the mechanism of HIV RT inhibitors |
Aug. 8, 2006 |
| 7078516 |
NUCLEOTIDE SEQUENCES DERIVED FROM THE GENOME OF RETROVIRUSES OF THE HIV-1, HIV-2 AND SIV TYPE, AND THEIR USES IN PARTICULAR FOR THE AMPLIFICATION OF THE GENOMES OF THESE RETROVIRUSES AND FOR T |
Jul. 18, 2006 |
| 7078039 |
Immunogenic composition |
Jul. 18, 2006 |
| 7078038 |
Gp120 mutants and biological applications |
Jul. 18, 2006 |
| 7071322 |
HIV envelope polynucleotides and immunogenic composition |
Jul. 4, 2006 |
| 7070787 |
Method of inducing the production of antibodies to HIV |
Jul. 4, 2006 |
| 7067246 |
Method for determining prognosis of HIV infected individuals |
Jun. 27, 2006 |
| 7067134 |
HIV vaccine |
Jun. 27, 2006 |
| 7063849 |
Use of HIV-1 gp120 and gp160 proteins modified in the v3 loop for the preparation of vaccine compositions and formulations containing the same |
Jun. 20, 2006 |
| 7056656 |
Tat-derived oligourea and its method of production and use in high affinity and specific binding HIV-1 TAR RNA |
Jun. 6, 2006 |
|
|
|
